期刊文献+

PDGF与子痫前期相关性的研究进展 被引量:2

Advances in Research on the Relationship between PDGF and Preeclampsia
下载PDF
导出
摘要 子痫前期是妊娠期特有的疾病,是一种多系统疾病,其特征在于高血压伴随母体或胎儿一种或多种其他器官系统损害。血小板源性生长因子(PDGF)是一种促有丝分裂剂,涉及细胞的迁徙、增殖、新血管形成及动脉粥样硬化病变的发生、发展。PDGF适度分泌释放对是否发生病理性妊娠极其关键,过度分泌可导致子痫前期胎盘血管病变。现将近年来与子痫前期有关的PDGF的研究进行总结。 Preeclampsia is a disease specific to pregnancy and is a multi-system disease characterized by hypertension accompanied by damage to one or more other organ systems of the mother or fetus.Platelet-derived growth factor(PDGF)is a mitogenic agent involved in cell migration,proliferation,neovascularization,and the development and progression of atherosclerotic lesions.Moderate secretion of PDGF is critical for the presence or absence of pathological pregnancy,and excessive secretion can lead to pre-eclamptic placental vasculopathy.The recent studies on PDGF related to preeclampsia are summarized.
作者 尤鑫 崔洪艳 YOU Xin;CUI Hong-yan(Gynecology Department,Tianjin Central Hospital of Obstetrics and Gynecology,Tianjin300100,China)
出处 《医学信息》 2019年第17期53-56,共4页 Journal of Medical Information
关键词 子痫前期 血小板源性生长因子 动脉粥样硬化病变 不良妊娠结局 Preeclampsia Platelet-derived growth factor Atherosclerotic lesions Adverse pregnancy outcomes
  • 相关文献

参考文献17

二级参考文献89

  • 1孟会,朱付凡,王晨虹,萧根秀.血小板生长因子与子痫前期发病的关系[J].南方医科大学学报,2007,27(8):1274-1276. 被引量:5
  • 2Scioscia M, Williams, PJ Gumaa K, et al. Inositol phosphoglycans and preeclampsia: from bench to bedside. J Reprod Immunol, 2011,89 : 173-177.
  • 3Kjeldsen L, Johnsen AH, Sengel H, et al. Isolation and primary structure of NGAL, a novel protein associated with human neu- trophilgelatinase. J Biol Chem, 1993,268 : 10425-10432.
  • 4Cowland JB, Sorensen OE, Sehested M, et al. NeutroPhil, gelati- nase-assoeiated, Lipocalin is up-regulated in human epithelial ceils by IL-lb, but not by TNF-a. J Immunol, 2003,171:6630-6639.
  • 5D'Anna R, Baviera G, Giordano D, et al. Neutrophil gelatinase-as- sociated lipocalin serum evaluation through normal pregnancy and in pregnancies complicated by preeclampsia. Acta Obstet Gynecol Scand, 2010,89 : 275-278.
  • 6Burton GJ, Scioseia M, Rademacher TW. Endometrial secretions: creating a stimulatory mieroenvironment within the human early pla- centa and implications for the aetiopathogenesis of preeelampsia. J Reprod Immunol, 2011,89 : 118-125.
  • 7Cetin I, Huppertz B, Burton G, et al. Pregenesys pre-eclampsia markers consensus meeting: what do we require from markers, risk assessment and model systems totailor preventive strategies? Placen- ta,2011,32: S4-S16.
  • 8Steegers EA, Von Dadelszen P, Duvekot JJ, et al. Preeclampsia. Lancet, 2010,376 : 631-644.
  • 9Grill S, Rusterholz C, Zanetti-Dallenbach R, et al. Potential markers of preeclampsia-areview. Reprod Biol Endocrinol, 2009,7: 70.
  • 10Wald N. Unified prenatal screening for Down's syndrome and pre- eclampsia. Clin Biochem, 2011,44:455.

共引文献118

同被引文献20

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部